scm logo

Song Sun-uk, vice president of SCM Life Science, received the Minister of Health and Welfare award at the BIO KOREA 2018 Health Industry Merit Award held at COEX in Seoul on the 10th. 

The BIO KOREA event, which started in 2006, is the only health industry convention in Korea that promotes the global capabilities of the bio health industry such as domestic pharmaceuticals and medical devices to the world. The Bio-pharmaceutical Industry Merit Award has been awarded to companies or research institutes that have contributed greatly to the development of the bio-pharmaceutical industry since 2014, the fifth time this year.

Song Sun-uk, vice president, patented in Korea, the United States, Japan, and China by developing a high-purity adult stem cell separation technology that can solve the purity problem of treatments, which was the biggest problem of existing adult stem cell treatments. Based on the technology, it was recognized for its contribution to enhancing national competitiveness in the stem cell field by enabling the development of low-cost, high-purity adult stem cell treatments that dramatically increased safety and effectiveness.

SCM Life Science is the only company in the world that develops stem cell treatments tailored to diseases using source technology that separates and cultivates adult stem cells with high purity. Currently, clinical trials for chronic and acute Graft versus host diseases and acute pancreatitis are underway, and clinical trials for atopic dermatitis and acute Graft versus host diseases will be conducted in Japan in the second-half of this year.